uman body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information:www.galderma.com.

References


Milotich A, et al. Economic potential of a next-generation ready-to-use liquid formulation of relabotulinumtoxin type A. Poster presented at AMWC 2026; March 26-28, 2026; Monaco

Grunebaum L D, et al. RelabotulinumtoxinA treatment improved moderate-to-severe glabellar lines and lateral canthal lines regardless of baseline toxin naivety: subgroup analyses of pooled Phase 3 study data. Poster presented at AMWC 2026; March 26-28, 2026; Monaco

Chadha P, et al. Consensus recommendations on the aesthetic use of relabotulinumtoxinA to treat upper face wrinkles. Poster presented at AMWC 2026; March 26-28, 2026; Mo
=*=*=*=*=*=
当前为第11/20页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页